Matches in SemOpenAlex for { <https://semopenalex.org/work/W71956044> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W71956044 abstract "Background A growing number of patients with cancer are at risk from chronic anthracycline cardiotoxicity (cAC) as a result of improving cancer prognosis. Although susceptibility is cumulative dose-related, it is also idiosyncratic. Furthermore, at present there is no way to reliably identify those at risk. The common practice of serially measuring LV ejection fraction (LVEF) only identifies cardiotoxicity after significant damage has been incurred. We hypothesised that risk of cAC could be determined from patient and treatment factors, known at baseline, together with assessment of the cardiac response to the 1st dose of anthracycline. Here we report the prevalence of cAC detected using CMR, together with the associations with baseline BP and anthracycline dose. Methods Women due to receive anthracycline-based chemotherapy for early breast cancer were recruited. Those with known cardiovascular disease were excluded. CMR was performed on Siemens 1.5T scanners before chemotherapy and at follow-up (>1 year after the final anthracycline cycle, and >3 months after Trastuzumab). LVEF was measured from cine images by a single operator (PK) blind to clinical and temporal data, using CMRtools. Chronic AC (cAC) was defined as a fall in absolute LVEF ≥5%. Results 164 subjects completed the study 18.5 [15.1-23.7] months after finishing treatment. 99% received epirubicin (400 [300-450] mg/m2). The mean fall in LVEF was 2.2% (p 20% of patients. Declines in resting LVEF are relatively late in the pathological process of cAC and therefore likely to reflect increased risk of heart failure as a ‘late-effect’ of cancer treatment. Our data suggest that undiagnosed hypertension was common; diagnosing and treating it may offer an opportunity to reduce cAC. A fall in LVEF ≥5% detected by CMR may be a better end-point for monitoring cardiotoxicity in oncology trials than those currently used. Although fibrosis is a hallmark of cAC based on biopsy" @default.
- W71956044 created "2016-06-24" @default.
- W71956044 creator A5012622514 @default.
- W71956044 creator A5016309817 @default.
- W71956044 creator A5035930156 @default.
- W71956044 creator A5061207169 @default.
- W71956044 creator A5068690871 @default.
- W71956044 creator A5077092467 @default.
- W71956044 creator A5084794636 @default.
- W71956044 creator A5086266525 @default.
- W71956044 creator A5086453071 @default.
- W71956044 creator A5089252660 @default.
- W71956044 date "2013-01-01" @default.
- W71956044 modified "2023-09-23" @default.
- W71956044 title "CMR shows that anthracycline cardiotoxicity is common in women treated for early breast cancer and associated with undiagnosed hypertension; but cannot be reliably detected using late-gadolinium enhancement imaging" @default.
- W71956044 doi "https://doi.org/10.1186/1532-429x-15-s1-p276" @default.
- W71956044 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3559904" @default.
- W71956044 hasPublicationYear "2013" @default.
- W71956044 type Work @default.
- W71956044 sameAs 71956044 @default.
- W71956044 citedByCount "1" @default.
- W71956044 countsByYear W719560442021 @default.
- W71956044 crossrefType "journal-article" @default.
- W71956044 hasAuthorship W71956044A5012622514 @default.
- W71956044 hasAuthorship W71956044A5016309817 @default.
- W71956044 hasAuthorship W71956044A5035930156 @default.
- W71956044 hasAuthorship W71956044A5061207169 @default.
- W71956044 hasAuthorship W71956044A5068690871 @default.
- W71956044 hasAuthorship W71956044A5077092467 @default.
- W71956044 hasAuthorship W71956044A5084794636 @default.
- W71956044 hasAuthorship W71956044A5086266525 @default.
- W71956044 hasAuthorship W71956044A5086453071 @default.
- W71956044 hasAuthorship W71956044A5089252660 @default.
- W71956044 hasBestOaLocation W719560441 @default.
- W71956044 hasConcept C121608353 @default.
- W71956044 hasConcept C126322002 @default.
- W71956044 hasConcept C126838900 @default.
- W71956044 hasConcept C143409427 @default.
- W71956044 hasConcept C143998085 @default.
- W71956044 hasConcept C164705383 @default.
- W71956044 hasConcept C2776694085 @default.
- W71956044 hasConcept C2776802502 @default.
- W71956044 hasConcept C2778233292 @default.
- W71956044 hasConcept C530470458 @default.
- W71956044 hasConcept C555175668 @default.
- W71956044 hasConcept C71924100 @default.
- W71956044 hasConceptScore W71956044C121608353 @default.
- W71956044 hasConceptScore W71956044C126322002 @default.
- W71956044 hasConceptScore W71956044C126838900 @default.
- W71956044 hasConceptScore W71956044C143409427 @default.
- W71956044 hasConceptScore W71956044C143998085 @default.
- W71956044 hasConceptScore W71956044C164705383 @default.
- W71956044 hasConceptScore W71956044C2776694085 @default.
- W71956044 hasConceptScore W71956044C2776802502 @default.
- W71956044 hasConceptScore W71956044C2778233292 @default.
- W71956044 hasConceptScore W71956044C530470458 @default.
- W71956044 hasConceptScore W71956044C555175668 @default.
- W71956044 hasConceptScore W71956044C71924100 @default.
- W71956044 hasIssue "S1" @default.
- W71956044 hasLocation W719560441 @default.
- W71956044 hasLocation W719560442 @default.
- W71956044 hasLocation W719560443 @default.
- W71956044 hasOpenAccess W71956044 @default.
- W71956044 hasPrimaryLocation W719560441 @default.
- W71956044 hasRelatedWork W202728438 @default.
- W71956044 hasRelatedWork W2110984210 @default.
- W71956044 hasRelatedWork W2165244953 @default.
- W71956044 hasRelatedWork W2184465471 @default.
- W71956044 hasRelatedWork W2591616149 @default.
- W71956044 hasRelatedWork W2592775069 @default.
- W71956044 hasRelatedWork W4289560474 @default.
- W71956044 hasRelatedWork W4311789423 @default.
- W71956044 hasRelatedWork W4312659673 @default.
- W71956044 hasRelatedWork W4367189272 @default.
- W71956044 hasVolume "15" @default.
- W71956044 isParatext "false" @default.
- W71956044 isRetracted "false" @default.
- W71956044 magId "71956044" @default.
- W71956044 workType "article" @default.